Literature DB >> 15752474

Development and validation of RP-HPLC method for cetrimonium bromide and lidocaine determination.

A Malenovic1, M Medenica, D Ivanovic, B Jancic, S Markovic.   

Abstract

The simple and rapid RP-HPLC method, for the simultaneous determination of lidocaine and cetrimonium bromide in the presence of pellet color corrigent, was developed. Separations were performed on a Beckman Ultrasphere ODS 4.6 mm x 15 cm, 5 microm particle column at 40 degrees C. The mobile phase consisted of water phase and acetonitrile (72:28 V/V), pH value of the mobile phase was adjusted to 2.0 with 85% ortophosphoric acid. Bisacodil was used as an internal standard. The flow rate was 1 ml/min and UV detection was performed at 208 nm. The proposed RP-HPLC method was validated and all the parameters for the validation of the method are given. According to the obtained results, the developed method was found to be suitable and accurate for the determination of these drugs in commercial formulations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752474     DOI: 10.1016/j.farmac.2004.11.004

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  Electro-oxidation mechanism and direct square-wave voltammetric determination of lidocaine with a carbon-paste electrode.

Authors:  Nadereh Rahbar; Zahra Ramezani; Ahmad Babapour
Journal:  Jundishapur J Nat Pharm Prod       Date:  2015-02-20

2.  Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.

Authors:  Yoon Hee Whang; Soo Kyung Kim; Hyeseon Yoon; Seuk Keun Choi; Yeong Ok Baik; Chankyu Lee; Inhwan Lee
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

3.  Evaluation of Lidocaine and Metabolite Pharmacokinetics in Hyaluronic Acid Injection.

Authors:  Ju Hee Kim; Dong Wook Kang; Go-Wun Choi; Sang Bok Lee; Seongjin Lee; Hea-Young Cho
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.